ANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component

Similar documents
Foundations of Pharmacology

II: Moderate Worsening airflow limitations Dyspnea on exertion, cough, and sputum production; patient usually seeks medical

Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath.

Chapter 22 Outline. Chapter 22: Respiratory and Gastrointestinal Drugs. Respiratory Drugs. Asthma. Respiratory Diseases 12/12/2011

Lungs SLO Practice (online) Page 1 of 5

Methacholine Challenge Test

Medications Affecting The Respiratory System

Diagnosis and Management of Asthma

Asthma. Definition. Symptoms

Asthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options

Allergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma

31 - Respiratory System

End Stage COPD Guidance Document

Asthma in Pregnancy. Asthma. Chronic Airway Inflammation. Objective Measures of Airflow. Peak exp. flow rate (PEFR)

Reference Guide for Caring for Pediatric Patients with Asthma

CLINICAL MEDICAL POLICY

A Visual Approach to Simplifying Respiratory Drug Regimens

Berkshire Allergy & Asthma Center 2210 Ridgewood Road, Suite 100 Wyomissing, PA (610)

Key features and changes to these four components of asthma care include:

Respiratory Medications and Devices Update 2/15

Clinical Policy: Omalizumab (Xolair) Reference Number: ERX.SPA.141 Effective Date: Last Review Date: 08.17

12/18/2017. Disclosures. Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing

APPENDIX 1 Printable point-of-care tables Asthma Action Plan Yellow Zone Formulation Table Region: Europe

A Visual Approach to Simplifying Respiratory Drug Regimens

Drug Class Monograph

A Visual Approach to Simplifying Respiratory Drug Regimens

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

Clinical Policy: Omalizumab (Xolair) Reference Number: ERX.SPA.141 Effective Date:

Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing

REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE

Question I was one of the first dry power devices available in the US Flovent, Serevent and Advair are all available in this device

10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C

Medications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources

ASTHMA IN THE PEDIATRIC POPULATION

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Effective Date: 4/27/2016 Version: 1.0 Approval By: CCC Clinical Delivery Steering Planned Review Date: 4/27/2017

Drugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN

Objectives. Speaker has no relationship to disclose. Sneezes, Wheezes, and Respiratory Diseases: An update on Asthma, Allergic Rhinitis,

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

Report generated from BNF provided by FormularyComplete ( Accessed Formulary Status. TA Number. Section.

Advanced Pharmacology Respiratory Pharmacology

SAMPLE. mg by mouth every day for day(s) Prednisolone. Other Medicine: Medicine Dose How long Directions

CAMPER APPLICATION PACKET

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

Breath of Fresh Air. Information, news and advice for improving asthma well-being. National Asthma Guidelines: A Stepped Approach to Asthma Therapy

Using Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless?

Clinical Policy: Dupilumab (Dupixent) Reference Number: ERX.SPA.49 Effective Date:

MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS

Nucala (mepolizumab injection for subcutaneous use)

The Inflammatory Response. Inflammation in the Airway. The Inflammatory Response. Inflammation in the Airway. Inflammation in the Airway

First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida

FASENRA (benralizumab)

Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS

Alberta Childhood Asthma Pathway for Primary Care

Drug Prior Authorization Guideline NUCALA (mepolizumab)

Adjustment of Inhaled Controller Therapy of Asthma in the Yellow Zone, Based on the Inhaler Product Used in the Green Zone Age 16 Years and Older

ASTHMA BEST PRACTICES FOR SCHOOL NURSES. School Nurses November 2015

Nancy Davis, RRT, AE-C

Provider Respiratory Inservice

Common Inhaled Asthma Medications Dose Comparison and Tips for Use

Asthma and COPD Drug Discoveries:

AT TRIAGE. Alberta Acute Childhood Asthma Pathway: Evidence based* recommendations For Emergency / Urgent Care

Clinical Policy: Mepolizumab (Nucala) Reference Number: ERX.SPA.214 Effective Date:

The Medical Letter. on Drugs and Therapeutics

Women Beware-The Threat of COPD

4/3/2018 BRANDY BURGESS, APRN-CNS, MSN-RN APRIL 12-14, 2018

Proposed Preferred Drug List. Clinical Criteria

Asthma By Mayo Clinic staff

The clinical quality measures as selected by the Clinical Management subcommittee for 2016 for the adult population are:

Cinqair (reslizumab injection for intravenous use)

See Important Reminder at the end of this policy for important regulatory and legal information.

benralizumab (Fasenra )

Global Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health

Bronchiectasis. Examples include: Viral infections (measles, adenovirus, influenza)

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

A Partnership in Quality Reporting. Effectiveness of Care: Prevention and Screening

TABLE OF CONTENTS (Click on a link below to view the section.)

Disclosure. Case. Objectives. Case Continued. Inhalers. Asthma: A GINA Update to the NAEPP 2007 Guidelines 1/20/2015

Women Beware The Threat of COPD

Aerospan (flunisolide)

TABLE OF CONTENTS (Click on a link below to view the section.)

Clinical Policy: Dupilumab (Dupixent) Reference Number: ERX.SPA.49 Effective Date:

Adjustment of Inhaled Controller Therapy of Asthma in the Yellow Zone, Based on the Inhaler Product Used in the Green Zone Age 12 Years and Older

UPMC HEALTH PLAN COPD CLINICAL PRACTICE GUIDELINE

Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma

AIRDUO RESPICLICK (fluticasone-salmeterol) aerosol DULERA (mometasone furoate and formoterol fumarate dihydrate) aerosol

Secretary for Health and Family Services Selections for Preferred Products

Asthma Pharmacotherapy 2017: Stepwise Approach to Managing Asthma

Select Inhaled Respiratory Agents

Asthma. doh.sd.gov/statistics/2009brfss/asthma.pdf

Inhaled Corticosteroid Dose Comparison in Asthma

2/4/2019 STEROIDS: THE GOOD, THE BAD AND THE UGLY! CONFLICT OF INTEREST, DISCLOSURES AND CONFESSIONS OUTLINE MICHAEL ZACHARISEN, MD.

Clinical Guideline for the Diagnosis, Evaluation, and Management of Adults and Children with Asthma

XOLAIR (omalizumab) Prior Authorization

Clinical Policy: Mepolizumab (Nucala) Reference Number: ERX.SPA.214 Effective Date:

Supplementary materials

Working Together to Better Manage Childhood Asthma

3/24/2017. Learning Objectives. Current Issues In Airway Pharmacology. Beta-Agonists. Bronchodilating Agents. Adrenergic Autonomic Control

Transcription:

ANTINEOPLASTIC DRUGS CHAPTER 21 Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component Tx of malignancies Antineoplastic drugs: methotrexate mechanism of action Oral Effects Dental Hygiene Management of patient taking Antineoplastic agents Before drug treatment During treatment After treatment

I. RESPIRATORY SYSTEM A. Respiratory diseases 1. Non-infectious RESPIRATORY & GASTROINTESTINAL DRUGS CHAPTER 22 2. Infectious 3. Ventilation Drive B. Respiratory Drugs Non-infectious disease 1. Sympathomimetic Agents (see Chapter 4) non-selective β agonists selective β2 agonists Drugs: albuterol: albuterol, ProAir HFA, Proventil HFA, Ventolin HFA Combivent: (albuterol + ipratropium) Advair HFA: (salmeterol + fluticasone) 2. Corticosteroids (see Chapter 19) Drugs: fluticasone (Advair discus, Flonase, Flovent) mometasone (Nasonex) budesonide (Rhinocort, Pulmicort) triamcinolone (Nasacort) prednisone 3. Leukotriene-Pathway Inhibitors (see Chapter 18)

Drugs: montelukast (Singulair) 4. Mast Cell Dregranulation Inhibitors Drugs: Cromolyn (Nasalcrom) [OTC] 5. Methylxanthines Drugs: theophylline, aminophylline 6. Anticholinergics (see Chapter 4) Drugs: ipratropium (Combivent / with albuterol) tiotropium (Spiriva) 7. Immune Response Modifiers : Drugs: omalizumab (Xolair) Infectious Disease 1. Antibiotics (see Chapter 8)

2. Nasal decongestants : Drugs: (see chapter 4) phenylpropanolamine pseudoephedrine (Sudafed) phenylephrine (Neo-Synephrine) 3. Expectorants MA Drugs: Guaifenesin [OTC] 4. Mucolytics MA Drugs: acetylcysteine 5. Antitussives MA DENTAL IMPLICATIONS of respiratory drugs About 10% of steroid-dependent asthmatics are allergic to sulfites (see pg. 6) Drugs: (see chapter 6) (allergy to sulfites is an absolute contraindication to vasoconstrictor) dextromethorphan pt should bring inhaler to appointment and have ready access to inhaler (acute asthmatic attack should be treated with fast-acting β2 agonist) look for oral candidiasis with inhaled steroid use inhalers (all drugs) can cause xerostomia

I. GASTROINTESTINAL SYSTEM A. GI Diseases 1. GERD (gastroesophageal reflux disease) tx: 2. Ulcers tx: 3. Chronic inflammatory bowel disease (IBD) a. ulcerative colitis b. Crohn s disease tx: B. GI Drugs 1. Histamine2-Blocking Agents (see chapter 18) Drugs: cimetidene (Tagamet) famotidine (Pepcid AC) ranitidine (Zantac) nizatidine (Axid) 2. Proton Pump Inhibitors (PPI) Drugs: omeprazole (Prilosec) lansoprazole (Previcid) pantoprazole (Protonix) rabeprazole (Aciphex) 3. Antacids (OTC) 4. Miscellaneous GI Drugs a. misoprostol (PGEα-2) b. sucralfate c. metoclopramide d. simethacone

Steroid-Dependent Asthma Definitions: 1. The Asthma Center specialists consider you "Steroid Dependent" if you receive corticosteroids in the following manner: frequent, short term oral corticosteroid treatment bursts in the past 12 months regular use of high dose inhaled corticosteroids in the past 12 months regular use of injected long acting corticosteroids daily use of oral corticosteroids alternate-day oral corticosteroids prolonged use of oral corticosteroids in the past year 2. A practical definition, useful for the clinician, is any patient who requires daily oral steroids (or very high doses of high-potency inhaled steroids) to minimize the frequency of asthma exacerbations. These patients are considered either steroid-dependent (normal pulmonary function maintained only if taking oral steroids) or steroid-resistant (poor pulmonary function despite treatment with oral steroids). from Severe Steroid-Dependent Asthma: Therapeutic Role of High-Dose Intravenous Immunoglobulin Nathan Rabinovitch, MD, Erwin W. Gelfand, MD Medscape General Medicine. 2000;2(1) 2000 Medscape Examples: A. Inhaled Corticosteroids 1. beclomethasone (QVAR) 40 mcg/puff 80 mcg / puff 2. budesonide (Pulmicort) 200 mcg, 250 mcg, 500 mcg 3. ciclesonide (Alvesco) 80 mcg, 160 mcg 4. flunisolide (Aerobid) 250 mcg 5. fluticasone MDI: Flovent HFA 44 mcg, 110 mcg, 220 mcg DPI: Advair HFA 100 mcg, 250 mcg, 500 mcg 6. mometasone furoate (Asmanex Twisthaler) 110 mcg, 220 mcg 7. triamcinolone (Azmacort) 200 mcg B. Oral Corticosteroids 1. prednisone 2. prednisolone 3. dexamethasone 4. methylprednisolone C. What is a high dose of inhaled corticosteroid? Low dose, for mild, persistent asthma Medium dose, for moderate, persistent asthma High dose, for severe, persistent asthma Beclomethasone Budesonide Flunisolide Fluticasone Fluticasone Triamcinolone (MDI) (DPI) 168-504 mcg 200-400 mcg 500-1000 mcg 88-264 mcg 100-300 mcg 400-1000 mcg 504-840 mcg 400-600 mcg 1000-2000 mcg 264-660 mcg 300-600 mcg 1000-2000 mcg > 840 mcg / day > 600 mcg/day > 2000 mcg/day > 660 mcg/day > 600 mcg/day > 2000 mcg/day